Breast Cancer Antiestrogen Resistance 3 (BCAR3) Promotes Cell Motility by Regulating Actin Cytoskeletal and Adhesion Remodeling in Invasive Breast Cancer Cells

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Wilson, Ashley L ^a   Schrecengost, Randy S ^b   Guerrero, Michael S ^a   Thomas, Keena S ^a   Bouton, Amy H ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ADAPTOR PROTEIN; BREAST CANCER ANTIESTROGEN RESISTANCE 3; MYOSIN LIGHT CHAIN 2; PROTEIN TYROSINE PHOSPHATASE SHP; RAC1 PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG; BCAR3 PROTEIN, HUMAN; CARDIAC MYOSIN; DIAPH1 PROTEIN, HUMAN; MYOSIN LIGHT CHAIN; RAC1 PROTEIN, HUMAN; RHO KINASE; RHOA PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL ADHESION; CELL MOTILITY; CONTROLLED STUDY; CYTOSKELETON; FOCAL ADHESION; PHOSPHORYLATION; PROTEIN DEPLETION; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TUMOR INVASION; ACTIN FILAMENT; BREAST; CELL MOTION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; TUMOR CELL LINE; ULTRASTRUCTURE;

ACTIN CYTOSKELETON; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BREAST; CARDIAC MYOSINS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MYOSIN LIGHT CHAINS; NEOPLASM INVASIVENESS; PHOSPHORYLATION; RAC1 GTP-BINDING PROTEIN; RHO-ASSOCIATED KINASES; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION;

EID: 84878799984     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065678     Document Type: Article

References (48)

1. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, et al. (2003) Cell migration: integrating signals from front to back. Science 302: 1704-1709.
2. Choi CK, Vicente-Manzanares M, Zareno J, Whitmore LA, Mogilner A, et al. (2008) Actin and alpha-actinin orchestrate the assembly and maturation of nascent adhesions in a myosin II motor-independent manner. Nat Cell Biol 10: 1039-1050.
3. Parsons JT, Horwitz AR, Schwartz MA, (2010) Cell adhesion: integrating cytoskeletal dynamics and cellular tension. Nat Rev Mol Cell Biol 11: 633-643.
4. Burridge K, Wennerberg K, (2004) Rho and Rac take center stage. Cell 116: 167-179.
5. Narumiya S, Tanji M, Ishizaki T, (2009) Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion. Cancer Metastasis Rev 28: 65-76.
6. Oakes PW, Beckham Y, Stricker J, Gardel ML, (2012) Tension is required but not sufficient for focal adhesion maturation without a stress fiber template. J Cell Biol 196: 363-374.
7. Guilluy C, Garcia-Mata R, Burridge K, (2011) Rho protein crosstalk: another social network? Trends Cell Biol 21: 718-726.
8. Machacek M, Hodgson L, Welch C, Elliott H, Pertz O, et al. (2009) Coordination of Rho GTPase activities during cell protrusion. Nature 461: 99-103.
9. Hood JD, Cheresh DA, (2002) Role of integrins in cell invasion and migration. Nat Rev Cancer 2: 91-100.
10. Schrecengost RS, Riggins RB, Thomas KS, Guerrero MS, Bouton AH, (2007) Breast cancer antiestrogen resistance-3 expression regulates breast cancer cell migration through promotion of p130Cas membrane localization and membrane ruffling. Cancer Res 67: 6174-6182.
11. Near RI, Zhang Y, Makkinje A, Vanden Borre P, Lerner A, (2007) AND-34/BCAR3 differs from other NSP homologs in induction of anti-estrogen resistance, cyclin D1 promoter activation and altered breast cancer cell morphology. J Cell Physiol 212: 655-665.
12. Klemke RL, Leng J, Molander R, Brooks PC, Vuori K, et al. (1998) CAS/Crk coupling serves as a "molecular switch" for induction of cell migration. J Cell Biol 140: 961-972.
13. Akakura S, Kar B, Singh S, Cho L, Tibrewal N, et al. (2005) C-terminal SH3 domain of CrkII regulates the assembly and function of the DOCK180/ELMO Rac-GEF. J Cell Physiol 204: 344-351.
14. Cabodi S, del Pilar Camacho-Leal M, Di Stefano P, Defilippi P, (2010) Integrin signalling adaptors: not only figurants in the cancer story. Nat Rev Cancer 10: 858-870.
15. Riggins RB, Quilliam LA, Bouton AH, (2003) Synergistic promotion of c-Src activation and cell migration by Cas and AND-34/BCAR3. J Biol Chem 278: 28264-28273.
16. Riggins RB, Thomas KS, Ta HQ, Wen J, Davis RJ, et al. (2006) Physical and functional interactions between Cas and c-Src induce tamoxifen resistance of breast cancer cells through pathways involving epidermal growth factor receptor and signal transducer and activator of transcription 5b. Cancer Res 66: 7007-7015.
17. Schuh NR, Guerrero MS, Schrecengost RS, Bouton AH, (2010) BCAR3 regulates Src/p130 Cas association, Src kinase activity, and breast cancer adhesion signaling. J Biol Chem 285: 2309-2317.
18. Makkinje A, Vanden Borre P, Near RI, Patel PS, Lerner A, (2012) Breast Cancer Anti-estrogen Resistance 3 (BCAR3) Augments Binding of the c-Src Kinase SH3 Domain to Crk-associated Substrate (p130Cas). J Biol Chem.
19. Ridley AJ, Paterson HF, Johnston CL, Diekmann D, Hall A, (1992) The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 70: 401-410.
20. Cai D, Iyer A, Felekkis KN, Near RI, Luo Z, et al. (2003) AND-34/BCAR3, a GDP exchange factor whose overexpression confers antiestrogen resistance, activates Rac, PAK1, and the cyclin D1 promoter. Cancer Res 63: 6802-6808.
21. Nobes CD, Hall A, (1995) Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 81: 53-62.
22. Burridge K, Chrzanowska-Wodnicka M, (1996) Focal adhesions, contractility, and signaling. Annu Rev Cell Dev Biol 12: 463-518.
23. Vega FM, Ridley AJ, (2008) Rho GTPases in cancer cell biology. FEBS Lett 582: 2093-2101.
24. Cai D, Clayton LK, Smolyar A, Lerner A, (1999) AND-34, a novel p130Cas-binding thymic stromal cell protein regulated by adhesion and inflammatory cytokines. J Immunol 163: 2104-2112.
25. Mace PD, Wallez Y, Dobaczewska MK, Lee JJ, Robinson H, et al. (2011) NSP-Cas protein structures reveal a promiscuous interaction module in cell signaling. Nat Struct Mol Biol 18: 1381-1387.
26. Cho SY, Klemke RL, (2002) Purification of pseudopodia from polarized cells reveals redistribution and activation of Rac through assembly of a CAS/Crk scaffold. J Cell Biol 156: 725-736.
27. Brugnera E, Haney L, Grimsley C, Lu M, Walk SF, et al. (2002) Unconventional Rac-GEF activity is mediated through the Dock180-ELMO complex. Nat Cell Biol 4: 574-582.
28. Vanden Borre P, Near RI, Makkinje A, Mostoslavsky G, Lerner A, (2011) BCAR3/AND-34 can signal independent of complex formation with CAS family members or the presence of p130Cas. Cell Signal 23: 1030-1040.
29. Sun G, Cheng SY, Chen M, Lim CJ, Pallen CJ, (2012) Protein tyrosine phosphatase alpha phosphotyrosyl-789 binds BCAR3 to position Cas for activation at integrin-mediated focal adhesions. Mol Cell Biol 32: 3776-3789.
30. Burnham MR, Bruce-Staskal PJ, Harte MT, Weidow CL, Ma A, et al. (2000) Regulation of c-SRC activity and function by the adapter protein CAS. Mol Cell Biol 20: 5865-5878.
31. Chang JH, Gill S, Settleman J, Parsons SJ, (1995) c-Src regulates the simultaneous rearrangement of actin cytoskeleton, p190RhoGAP, and p120RasGAP following epidermal growth factor stimulation. J Cell Biol 130: 355-368.
32. Huveneers S, Danen EH, (2009) Adhesion signaling- crosstalk between integrins, Src and Rho. J Cell Sci 122: 1059-1069.
33. Guilluy C, Swaminathan V, Garcia-Mata R, O'Brien ET, Superfine R, et al. (2011) The Rho GEFs LARG and GEF-H1 regulate the mechanical response to force on integrins. Nat Cell Biol 13: 722-727.
34. Biscardi JS, Tice DA, Parsons SJ, (1999) c-Src, receptor tyrosine kinases, and human cancer. Adv Cancer Res 76: 61-119.
35. van der Flier S, Brinkman A, Look MP, Kok EM, Meijer-van Gelder ME, et al. (2000) Bcar1/p130Cas protein and primary breast cancer: prognosis and response to tamoxifen treatment. J Natl Cancer Inst 92: 120-127.
36. Ishizawar R, Parsons SJ, (2004) c-Src and cooperating partners in human cancer. Cancer Cell 6: 209-214.
37. Yeatman TJ, (2004) A renaissance for SRC. Nat Rev Cancer 4: 470-480.
38. Riggins RB, Schrecengost RS, Guerrero MS, Bouton AH, (2007) Pathways to tamoxifen resistance. Cancer Lett 256: 1-24.
39. Guerrero MS, Parsons JT, Bouton AH, (2012) Cas and NEDD9 Contribute to Tumor Progression through Dynamic Regulation of the Cytoskeleton. Genes & Cancer.
40. Finn RS, (2008) Targeting Src in breast cancer. Ann Oncol 19: 1379-1386.
41. Carey L, Winer E, Viale G, Cameron D, Gianni L, (2010) Triple-negative breast cancer: disease entity or title of convenience? Nat Rev Clin Oncol 7: 683-692.
42. Wang W, Eddy R, Condeelis J, (2007) The cofilin pathway in breast cancer invasion and metastasis. Nat Rev Cancer 7: 429-440.
43. Musgrove EA, Sutherland RL, (2009) Biological determinants of endocrine resistance in breast cancer. Nat Rev Cancer 9: 631-643.
44. Corkery B, Crown J, Clynes M, O'Donovan N, (2009) Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer. Ann Oncol 20: 862-867.
45. Wyckoff J, Wang W, Lin EY, Wang Y, Pixley F, et al. (2004) A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 64: 7022-7029.
46. Vervoort VS, Roselli S, Oshima RG, Pasquale EB, (2007) Splice variants and expression patterns of SHEP1, BCAR3 and NSP1, a gene family involved in integrin and receptor tyrosine kinase signaling. Gene 391: 161-170.
47. Near RI, Smith RS, Toselli PA, Freddo TF, Bloom AB, et al. (2009) Loss of AND-34/BCAR3 expression in mice results in rupture of the adult lens. Mol Vis 15: 685-699.
48. Bouton AH, Burnham MR, (1997) Detection of distinct pools of the adapter protein p130CAS using a panel of monoclonal antibodies. Hybridoma 16: 403-411.